Clinical Trial Update: Effect of Rosuvastatin on Left Ventricular Remodeling [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated the effect of rosuvastatin on left ventricular remodeling in patients with dilated cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Dilated Cardiomyopathy | Phase 3 | Status: COMPLETED